Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Phenotype-specific recombinant haptoglobin polymers co-expressed with C1r-like protein as optimized hemoglobin-binding therapeutics.

Schaer CA, Owczarek C, Deuel JW, Schauer S, Baek JH, Yalamanoglu A, Hardy MP, Scotney PD, Schmidt PM, Pelzing M, Soupourmas P, Buehler PW, Schaer DJ.

BMC Biotechnol. 2018 Mar 15;18(1):15. doi: 10.1186/s12896-018-0424-3.

2.

Current standards of neuropsychological assessment in epilepsy surgery centers across Europe.

Vogt VL, Äikiä M, Del Barrio A, Boon P, Borbély C, Bran E, Braun K, Carette E, Clark M, Cross JH, Dimova P, Fabo D, Foroglou N, Francione S, Gersamia A, Gil-Nagel A, Guekht A, Harrison S, Hecimovic H, Heminghyt E, Hirsch E, Javurkova A, Kälviäinen R, Kavan N, Kelemen A, Kimiskidis VK, Kirschner M, Kleitz C, Kobulashvili T, Kosmidis MH, Kurtish SY, Lesourd M, Ljunggren S, Lossius MI, Malmgren K, Mameniskiené R, Martin-Sanfilippo P, Marusic P, Miatton M, Özkara Ç, Pelle F, Rubboli G, Rudebeck S, Ryvlin P, van Schooneveld M, Schmid E, Schmidt PM, Seeck M, Steinhoff BJ, Shavel-Jessop S, Tarta-Arsene O, Trinka E, Viggedal G, Wendling AS, Witt JA, Helmstaedter C; E-PILEPSY consortium.

Epilepsia. 2017 Mar;58(3):343-355. doi: 10.1111/epi.13646. Epub 2017 Jan 9.

3.

Aluminum exposure for one hour decreases vascular reactivity in conductance and resistance arteries in rats.

Schmidt PM, Escobar AG, Torres JG, Martinez CS, Rizzetti DA, Kunz SN, Vassallo DV, Alonso MJ, Peçanha FM, Wiggers GA.

Toxicol Appl Pharmacol. 2016 Dec 15;313:109-118. doi: 10.1016/j.taap.2016.10.023. Epub 2016 Oct 27.

4.

A robust robotic high-throughput antibody purification platform.

Schmidt PM, Abdo M, Butcher RE, Yap MY, Scotney PD, Ramunno ML, Martin-Roussety G, Owczarek C, Hardy MP, Chen CG, Fabri LJ.

J Chromatogr A. 2016 Jul 15;1455:9-19. doi: 10.1016/j.chroma.2016.05.076. Epub 2016 May 24.

PMID:
27283099
5.

Targeting coagulation factor XII as a novel therapeutic option in brain trauma.

Hopp S, Albert-Weissenberger C, Mencl S, Bieber M, Schuhmann MK, Stetter C, Nieswandt B, Schmidt PM, Monoranu CM, Alafuzoff I, Marklund N, Nolte MW, Sirén AL, Kleinschnitz C.

Ann Neurol. 2016 Jun;79(6):970-82. doi: 10.1002/ana.24655. Epub 2016 Apr 28.

6.

From Baghdad to Boston: international transfer of burned children in time of war.

Schmidt PM, Sheridan RL, Moore CL, Scuba SC, King BT, Morrissey PM, Cancio LC.

J Burn Care Res. 2014 Sep-Oct;35(5):369-73. doi: 10.1097/BCR.0b013e3182a366f1.

PMID:
24121805
7.

Receptor binding assay for NO-independent activators of soluble guanylate cyclase.

Schmidt PM, Stasch JP.

Methods Mol Biol. 2013;1020:205-14. doi: 10.1007/978-1-62703-459-3_13.

PMID:
23709035
8.

Taking down the FLAG! How insect cell expression challenges an established tag-system.

Schmidt PM, Sparrow LG, Attwood RM, Xiao X, Adams TE, McKimm-Breschkin JL.

PLoS One. 2012;7(6):e37779. doi: 10.1371/journal.pone.0037779. Epub 2012 Jun 6.

9.

Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza viruses.

Barrett S, Mohr PG, Schmidt PM, McKimm-Breschkin JL.

PLoS One. 2011;6(8):e23627. doi: 10.1371/journal.pone.0023627. Epub 2011 Aug 17.

10.

Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells.

Hoffmann LS, Schmidt PM, Keim Y, Hoffmann C, Schmidt HH, Stasch JP.

PLoS One. 2011;6(8):e23596. doi: 10.1371/journal.pone.0023596. Epub 2011 Aug 17.

11.

A generic system for the expression and purification of soluble and stable influenza neuraminidase.

Schmidt PM, Attwood RM, Mohr PG, Barrett SA, McKimm-Breschkin JL.

PLoS One. 2011 Feb 7;6(2):e16284. doi: 10.1371/journal.pone.0016284.

12.

Balance assessment in alcoholic subjects.

Schmidt PM, Giordani AM, Rossi AG, Cóser PL.

Braz J Otorhinolaryngol. 2010 Mar-Apr;76(2):148-55.

13.

Hearing and vestibular complaints during pregnancy.

Schmidt PM, Flores Fda T, Rossi AG, Silveira AF.

Braz J Otorhinolaryngol. 2010 Jan-Feb;76(1):29-33.

14.

Biodiversity conservation and indigenous land management in the era of self-determination.

Schmidt PM, Peterson MJ.

Conserv Biol. 2009 Dec;23(6):1458-66. doi: 10.1111/j.1523-1739.2009.01262.x. Epub 2009 Jun 8.

PMID:
19508673
15.

Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation.

Meurer S, Pioch S, Pabst T, Opitz N, Schmidt PM, Beckhaus T, Wagner K, Matt S, Gegenbauer K, Geschka S, Karas M, Stasch JP, Schmidt HH, Müller-Esterl W.

Circ Res. 2009 Jul 2;105(1):33-41. doi: 10.1161/CIRCRESAHA.109.198234. Epub 2009 May 28.

PMID:
19478201
16.

Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.

Hoffmann LS, Schmidt PM, Keim Y, Schaefer S, Schmidt HH, Stasch JP.

Br J Pharmacol. 2009 Jul;157(5):781-95. doi: 10.1111/j.1476-5381.2009.00263.x. Epub 2009 May 18.

17.

NO- and haem-independent soluble guanylate cyclase activators.

Schmidt HH, Schmidt PM, Stasch JP.

Handb Exp Pharmacol. 2009;(191):309-39. doi: 10.1007/978-3-540-68964-5_14. Review.

PMID:
19089335
18.

Biochemical Detection of cGMP From Past to Present: An Overview.

Schmidt PM.

Handb Exp Pharmacol. 2009;(191):195-228. doi: 10.1007/978-3-540-68964-5_10. Review.

PMID:
19089331
19.

Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo.

Rothkegel C, Schmidt PM, Atkins DJ, Hoffmann LS, Schmidt HH, Schröder H, Stasch JP.

Mol Pharmacol. 2007 Nov;72(5):1181-90. Epub 2007 Aug 22.

20.

Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.

Stasch JP, Schmidt PM, Nedvetsky PI, Nedvetskaya TY, H S AK, Meurer S, Deile M, Taye A, Knorr A, Lapp H, Müller H, Turgay Y, Rothkegel C, Tersteegen A, Kemp-Harper B, Müller-Esterl W, Schmidt HH.

J Clin Invest. 2006 Sep;116(9):2552-61.

21.

NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.

Evgenov OV, Pacher P, Schmidt PM, Haskó G, Schmidt HH, Stasch JP.

Nat Rev Drug Discov. 2006 Sep;5(9):755-68. Review.

22.

Identification of residues crucially involved in soluble guanylate cyclase activation.

Rothkegel C, Schmidt PM, Stoll F, Schröder H, Schmidt HH, Stasch JP.

FEBS Lett. 2006 Jul 24;580(17):4205-13. Epub 2006 Jul 5.

23.

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells.

Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S, Hoertnagl H, Raine CS, Schneider-Stock R, Nitsch R, Ullrich O.

Neuron. 2006 Jan 5;49(1):67-79.

24.

Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases.

Beyer V, Mühlematter D, Parlier V, Cabrol C, Bougeon-Mamin S, Solenthaler M, Tobler A, Pugin P, Gregor M, Hitz F, Hess U, Chapuis B, Laurencet F, Schanz U, Schmidt PM, van Melle G, Jotterand M.

Cancer Genet Cytogenet. 2005 Jul 15;160(2):97-119. Review.

PMID:
15993266
25.

Residues stabilizing the heme moiety of the nitric oxide sensor soluble guanylate cyclase.

Schmidt PM, Rothkegel C, Wunder F, Schröder H, Stasch JP.

Eur J Pharmacol. 2005 Apr 18;513(1-2):67-74. Epub 2005 Apr 8.

PMID:
15878710
26.

Oligonucleotide microarray for identification of Bacillus anthracis based on intergenic transcribed spacers in ribosomal DNA.

Nübel U, Schmidt PM, Reiss E, Bier F, Beyer W, Naumann D.

FEMS Microbiol Lett. 2004 Nov 15;240(2):215-23.

27.

Real-time analysis on microarrays.

Bier FF, Ehrentreich-Förster E, Schmidt PM.

Anal Bioanal Chem. 2004 Jan;378(1):52-3. Epub 2003 Nov 13. No abstract available.

PMID:
14615870
28.

Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase.

Schmidt PM, Schramm M, Schröder H, Wunder F, Stasch JP.

J Biol Chem. 2004 Jan 23;279(4):3025-32. Epub 2003 Oct 21.

29.

Real-time determination of telomerase activity in cell extracts using an optical biosensor.

Schmidt PM, Matthes E, Scheller FW, Bienert M, Lehmann C, Ehrlich A, Bier FF.

Biol Chem. 2002 Oct;383(10):1659-66.

PMID:
12452442
30.

Detection of activity of telomerase in tumor cells using fiber optical biosensors.

Schmidt PM, Lehmann C, Matthes E, Bier FF.

Biosens Bioelectron. 2002 Dec;17(11-12):1081-87.

PMID:
12392959
31.

Determination of the turnover number of the restriction endonuclease EcoRI using evanescent wave technology.

Bier FF, Kleinjung F, Schmidt PM, Scheller FW.

Anal Bioanal Chem. 2002 Jan;372(2):308-13. Epub 2001 Dec 21.

PMID:
11936104
32.

Factors affecting the efficiency of embryo cryopreservation and rederivation of rat and mouse models.

Rall WF, Schmidt PM, Lin X, Brown SS, Ward AC, Hansen CT.

ILAR J. 2000;41(4):221-7. Review.

PMID:
11123182
33.

CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.

Baur AS, Meugé-Moraw C, Schmidt PM, Parlier V, Jotterand M, Delacrétaz F.

Eur J Haematol. 2000 Feb;64(2):71-9.

PMID:
10997326
34.

Superovulation of rabbits with FSH alters in vivo development of vitrified morulae.

Kauffman RD, Schmidt PM, Rall WF, Hoeg JM.

Theriogenology. 1998 Nov;50(7):1081-92.

PMID:
10734425
35.

Systemic mastocytosis following a malignant ovarian germ cell tumour.

Delacrétaz F, Stalder M, Meugé-Moraw C, Schmidt PM, Joris F, Kurt AM, De Werra P.

Histopathology. 1997 Jun;30(6):582-4.

PMID:
9205864
36.

Combined effects of interleukin-3 and interleukin-11 on hematopoiesis in irradiated mice.

Galmiche MC, Vogel CA, Delaloye AB, Schmidt PM, Healy F, Mach JP, Buchegger F.

Exp Hematol. 1996 Sep;24(11):1298-306.

PMID:
8862440
37.

Tetrasomy 8 in a patient with acute nonlymphocytic leukemia: a metaphase and interphase study with fluorescence in situ hybridization.

Mühlematter D, Castagné C, Bruzzese O, Clément F, Schmidt PM, Bellomo MJ.

Cancer Genet Cytogenet. 1996 Jul 1;89(1):44-8.

PMID:
8689609
38.
39.

Characterization of interacting ferrocene-cyclodextrin systems and their role in mediated biosensors.

Luong JH, Brown RS, Schmidt PM.

J Mol Recognit. 1995 Jan-Apr;8(1-2):132-8.

PMID:
7598946
40.

Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings.

Parlier V, van Melle G, Beris P, Schmidt PM, Tobler A, Haller E, Bellomo MJ.

Cancer Genet Cytogenet. 1994 Dec;78(2):219-31.

PMID:
7828157
41.

[Acquired factor V inhibitor treated with intravenous immunoglobulins].

Buclin T, Schmidt PM, Hauert J, Winkel L, Chapuis G, Bachmann F.

Schweiz Med Wochenschr. 1992 Dec 26;122(51-52):1968-70. French.

PMID:
1475662
42.

Lack of antibody specificity by mouse trophectoderm during immunosurgery.

Schiewe MC, Hansen CT, Schmidt PM.

Theriogenology. 1992 Jul;38(1):21-32.

PMID:
16727115
43.

t(8;9)(p11;q32) in atypical chronic myeloid leukaemia: a new cytogenetic-clinicopathologic association?

Jotterand Bellomo M, Mühlematter D, Wicht M, Delacrétaz F, Schmidt PM.

Br J Haematol. 1992 Jun;81(2):307-8. No abstract available.

PMID:
1643030
44.

[Hematological aspects of acro-syndromes].

Schmidt PM.

Rev Med Suisse Romande. 1992 May;112(5):413-6. French. No abstract available.

PMID:
1604102
45.

The temporal relationship of psychosocial stress to cellular immunity and herpes labialis recurrences.

Schmidt DD, Schmidt PM, Crabtree BF, Hyun J, Anderson P, Smith C.

Fam Med. 1991 Nov-Dec;23(8):594-9. Review.

PMID:
1794671
46.

[Persistent B-cell polyclonal lymphocytosis: a benign lymphoproliferative syndrome].

Tissot JD, Schmidt PM, von Fliedner V, Knecht H.

Schweiz Med Wochenschr. 1991 Oct 26;121(43):1582-4. French.

PMID:
1947954
47.

Dysmegakaryopoiesis predicting response to therapy in acute myeloid leukaemia. A histologic and clinical study.

Delacrétaz F, Spertini O, Schmidt PM, Grob JP.

Pathol Res Pract. 1991 Mar;187(2-3):290-5.

PMID:
2068013
48.

Cytogenetic analysis of 54 cases of myelodysplastic syndrome.

Jotterand-Bellomo M, Parlier V, Schmidt PM, Beris P.

Cancer Genet Cytogenet. 1990 Jun;46(2):157-72.

PMID:
2340487
49.

[Visceral leishmaniasis (kala-azar) and HIV infection. Apropos of a case and literature review].

Joggi J, Chave JP, Bruni D, Schmidt PM.

Schweiz Med Wochenschr. 1990 Mar 24;120(12):414-6. Review. French.

PMID:
2181645
50.

The individual over time: time series applications in health care research.

Crabtree BF, Ray SC, Schmidt PM, O'Connor PJ, Schmidt DD.

J Clin Epidemiol. 1990;43(3):241-60.

PMID:
2313315

Supplemental Content

Loading ...
Support Center